Randomisation? [Study Per­for­mance]

posted by khaoula – Algeria, 2014-06-11 02:17 (3988 d 05:02 ago) – Posting: # 13056
Views: 18,234

Hi ElMaestro & Helmut
I think that it's important to have randomisation of subject 15 (I dont now the basis of a software (kinetica) and how tu use it), I havnt randomisation because they dont give me it, they asked me to try to understand where is the error, so when I search I found that oeprazole is a HVDP and I try to understand what FDA and EMA do, I concluded that our design is't appropriate (must have replicate design), but with Phoenix/WinNonlin CV=23.37%, so the problem of our study is number of subject, with hightest number we can conclude to biequivalence (the test drug is really bioequivalent of réference, this study was done to learn how to do biequivalennce study)


I calculated CV with error = 0.0471261 and I had CV% = 100√(ℯ0.0471261 – 1) = 21.97% but I thought that I was wrong

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
80 visitors (0 registered, 80 guests [including 5 identified bots]).
Forum time: 07:19 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5